[BAUTO] QoQ TTM Result on 31-Jan-2023 [#3]

Stock
[BAUTO] BERMAZ AUTO BERHAD
Announcement Date
13-Mar-2023
Admission Sponsor
-
Sponsor
-
Financial Year
30-Apr-2023
Quarter
31-Jan-2023 [#3]
Profit Trend
QoQ- 19.8%
YoY- 95.92%
Quarter Report
Latest QR
Upcoming QR
BAUTO's Result
BAUTO's Financial Summary
View:
Show?
TTM Result
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
Revenue 4,144,595 3,920,613 3,548,204 3,373,166 3,020,329 2,721,198 2,325,121 46.85%
PBT 518,550 487,305 421,204 397,103 336,699 278,659 218,570 77.60%
Tax -115,130 -108,798 -93,982 -96,650 -85,708 -73,554 -59,741 54.67%
NP 403,420 378,507 327,222 300,453 250,991 205,105 158,829 85.84%
-
NP to SH 378,225 353,802 303,742 281,824 235,247 195,613 155,721 80.39%
-
Tax Rate 22.20% 22.33% 22.31% 24.34% 25.46% 26.40% 27.33% -
Total Cost 3,741,175 3,542,106 3,220,982 3,072,713 2,769,338 2,516,093 2,166,292 43.80%
-
Net Worth 769,460 736,595 761,919 707,075 660,791 629,909 634,319 13.70%
Dividend
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
Div 297,204 279,608 256,106 180,174 153,970 130,731 101,672 104.04%
Div Payout % 78.58% 79.03% 84.32% 63.93% 65.45% 66.83% 65.29% -
Equity
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
Net Worth 769,460 736,595 761,919 707,075 660,791 629,909 634,319 13.70%
NOSH 1,170,190 1,169,283 1,168,316 1,165,834 1,163,964 1,163,964 1,163,959 0.35%
Ratio Analysis
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
NP Margin 9.73% 9.65% 9.22% 8.91% 8.31% 7.54% 6.83% -
ROE 49.15% 48.03% 39.87% 39.86% 35.60% 31.05% 24.55% -
Per Share
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
RPS 355.72 335.86 304.38 289.96 259.99 234.14 200.06 46.61%
EPS 32.46 30.31 26.06 24.23 20.25 16.83 13.40 80.07%
DPS 25.50 24.00 22.00 15.50 13.25 11.25 8.75 103.63%
NAPS 0.6604 0.631 0.6536 0.6078 0.5688 0.542 0.5458 13.50%
Adjusted Per Share Value based on latest NOSH - 1,165,834
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
RPS 353.58 334.47 302.70 287.77 257.67 232.15 198.36 46.85%
EPS 32.27 30.18 25.91 24.04 20.07 16.69 13.28 80.45%
DPS 25.35 23.85 21.85 15.37 13.14 11.15 8.67 104.07%
NAPS 0.6564 0.6284 0.65 0.6032 0.5637 0.5374 0.5411 13.70%
Price Multiplier on Financial Quarter End Date
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
Date 31/10/23 31/07/23 28/04/23 31/01/23 31/10/22 29/07/22 29/04/22 -
Price 2.50 2.05 2.31 2.17 1.98 1.77 1.77 -
P/RPS 0.70 0.61 0.76 0.75 0.76 0.76 0.88 -14.11%
P/EPS 7.70 6.76 8.87 8.96 9.78 10.52 13.21 -30.15%
EY 12.98 14.78 11.28 11.16 10.23 9.51 7.57 43.11%
DY 10.20 11.71 9.52 7.14 6.69 6.36 4.94 61.93%
P/NAPS 3.79 3.25 3.53 3.57 3.48 3.27 3.24 10.98%
Price Multiplier on Announcement Date
31/10/23 31/07/23 30/04/23 31/01/23 31/10/22 31/07/22 30/04/22 CAGR
Date 12/12/23 12/09/23 12/06/23 13/03/23 08/12/22 12/09/22 13/06/22 -
Price 2.30 2.18 2.23 2.12 1.99 1.83 1.78 -
P/RPS 0.65 0.65 0.73 0.73 0.77 0.78 0.89 -18.85%
P/EPS 7.09 7.19 8.56 8.75 9.83 10.87 13.28 -34.11%
EY 14.11 13.90 11.68 11.43 10.18 9.20 7.53 51.81%
DY 11.09 11.01 9.87 7.31 6.66 6.15 4.92 71.65%
P/NAPS 3.48 3.45 3.41 3.49 3.50 3.38 3.26 4.43%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment